Researchers at Sanford Burnham Prebys reported in Science Advances that a protein called SORLA may help protect the brain against the abnormal tau proteins that form tangles in Alzheimer's and related conditions. In experiments with mice, boosting SORLA reduced several damaging changes, including brain shrinkage and the buildup of abnormal tau.
Tau normally helps stabilize microtubules, the small internal structures that support nerve cells. In Alzheimer's and other tauopathies, tau can become abnormal and clump into tangles that disrupt nerve cell function and are associated with cognitive decline and cell death. Earlier work from the same group and others had shown that SORLA limits the production of amyloid-beta, the protein that forms plaques, but little was known about whether it affected tau.
To test this, the team bred mice engineered to make extra human SORLA with mice that develop tau tangles, brain atrophy and cognitive impairment. Extra SORLA reduced hyperphosphorylation of tau, limited misfolded tau's ability to seed further clumping, and helped preserve synapses and synaptic plasticity. When the researchers instead removed the Sorl1 gene so mice could not make SORLA, the harmful effects were worse.
The team also found that higher SORLA levels reduced abnormal gene activity in glial cells, which support and protect neurons, and that a plexin-B family receptor became more active when SORLA was missing. Because drugs that target this receptor family already exist, the authors suggested they could be tested against tau-related dementia. The authors noted that the work was done in mice, and that more research is needed to understand how these mechanisms work in people. They plan to transplant human neurons and glial cells into mouse brains to study SORLA in a setting closer to human disease.